These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18123723)

  • 1. Metastatic carcinoma of the mastoid, following carcinoma of the prostate.
    FELDBERG I
    Ann Otol Rhinol Laryngol; 1948 Dec; 57(4):1099-1101. PubMed ID: 18123723
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogenic therapy on osseous metastases from carcinoma of the prostate.
    MacCARTY WC
    Radiology; 1947 Jul; 49(1):54-61. PubMed ID: 20252941
    [No Abstract]   [Full Text] [Related]  

  • 3. [Skeletal metastases of carcinoma of the prostate].
    VENTURI R
    Chir Organi Mov; 1963 Jan; 51():212-39. PubMed ID: 13996683
    [No Abstract]   [Full Text] [Related]  

  • 4. CARCINOMA OF THE PROSTATE WITH METASTASES TO THE JAW.
    MATIAS PI; SHNIDER BI; GOLD GL
    Med Ann Dist Columbia; 1965 Aug; 34():369-70 PASSIM. PubMed ID: 14338449
    [No Abstract]   [Full Text] [Related]  

  • 5. Distant metastases from prostatic carcinoma express androgen receptor protein.
    Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
    Cancer Res; 1995 Jul; 55(14):3068-72. PubMed ID: 7541709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraplegia as the result of metastasis from carcinoma of the prostate gland.
    TOULSON WH; HAWKINS CW
    Bull Sch Med Univ Md; 1948 Jan; 32(4):159-62. PubMed ID: 18898052
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic mammary carcinoma of the middle ear and mastoid.
    Shapoory R
    Laryngoscope; 1965 Nov; 75(11):1756-60. PubMed ID: 5842398
    [No Abstract]   [Full Text] [Related]  

  • 8. [REGRESSION OF A HISTOLOGICALLY CONFIRMED METASTATIC PULMONARY CARCINOSIS IN PROSTATE CARCINOMA UNDER HORMONE THERAPY].
    AHLENDORF W
    Z Tuberk Erkr Thoraxorg; 1963 Oct; 120():345-7. PubMed ID: 14093674
    [No Abstract]   [Full Text] [Related]  

  • 9. Unilateral exophthalmos secondary to metastatic carcinoma of the prostate: case report and review of the literature.
    HARPER JM; HUNTER WA
    J Urol; 1963 Jan; 89():75-7. PubMed ID: 13952885
    [No Abstract]   [Full Text] [Related]  

  • 10. Tracking the origin of metastatic prostate cancer.
    Lindberg J; Kristiansen A; Wiklund P; Grönberg H; Egevad L
    Eur Urol; 2015 May; 67(5):819-22. PubMed ID: 25246081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of factor VII in patients with carcinoma of the prostate. A preliminary report.
    van Deijk WA; van Dam-Mieras MC; Muller AD
    Haemostasis; 1983; 13(3):198-200. PubMed ID: 6193041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.
    Ost P; Decaestecker K; Lambert B; Fonteyne V; Delrue L; Lumen N; Ameye F; De Meerleer G
    Prostate; 2014 Feb; 74(3):297-305. PubMed ID: 24395565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle ear and mastoid neoplasms.
    Goodmann ML
    Ann Otol Rhinol Laryngol; 1971 Jun; 80(3):419-24. PubMed ID: 4325381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphadenography in the study of metastatic processes in neoplasms of the pelvic organs. I. Results obtained in the study of metastatic localizations of bladder and prostate neoplasms].
    Reina A; Alberti N; Bianca T; Rasà G; Polto F
    Chir Patol Sper; 1968 Oct; 16(5):481-502. PubMed ID: 5740901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostatic metastases as a differential diagnostic problem].
    Mehlhorn J
    Zentralbl Allg Pathol; 1987; 133(4):351-3. PubMed ID: 3425014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells.
    Taddei ML; Parri M; Angelucci A; Bianchini F; Marconi C; Giannoni E; Raugei G; Bologna M; Calorini L; Chiarugi P
    Mol Cancer Res; 2011 Feb; 9(2):149-60. PubMed ID: 21205836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
    Yilmaz M; Celen Z; Sevinc A; Karakok M
    Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
    Chen G; Sircar K; Aprikian A; Potti A; Goltzman D; Rabbani SA
    Cancer; 2006 Jul; 107(2):289-98. PubMed ID: 16752412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.